| Financial Year |
March 31 2023 |
| Monetary Funds |
886,056,515.86 |
| Held-for-trading Financial Assets |
16,200,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
257,273,473.09 |
| Advances to Suppliers |
12,334,355.66 |
| Other Receivables |
5,084,416.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,435,124.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,085,438.68 |
| Total Current Assets |
1,459,685,832.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
235,828,401.34 |
| Investment Properties |
134,593,093.13 |
| Fixed Assetes |
477,126,761.25 |
| Under-construction Projects |
283,401,881.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
126,652,155.49 |
| R&D expenses |
-- |
| Goodwill |
4,459,367.15 |
| Long-Term Deferred and Prepaid Expenses |
5,598,061.11 |
| Deferred Income Tax Assets |
16,384,621.91 |
| Other Non-Current Assets |
222,340,177.15 |
| Sub-Total of Non-Current Assets |
1,508,934,328.87 |
| Total Assets |
2,968,620,161.83 |
| Short-Term Loans |
136,883,950.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
132,311,390.71 |
| Accounts Payable |
99,393,259.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,704,357.36 |
| Taxes Payable |
11,740,856.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,719,316.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
76,926,267.47 |
| Other Current Liabilities |
996,299.34 |
| Sub-Total of Current Liabilities |
488,743,024.61 |
| Long-term Loans |
104,532,796.91 |
| Bonds Payable |
468,931,913.21 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
611,726,401.09 |
| Total Liabilities |
1,100,469,425.70 |
| Paid-In Capital(Or Share Stock) |
193,531,505.00 |
| Capital Surplus |
825,222,815.81 |
| Surplus Reserve |
59,749,924.69 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
544,962,269.71 |
| Minority Stockholder's Interest |
86,252,343.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,781,898,392.23 |
| Owner's Equity（Stockholder's Equity） |
1,868,150,736.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,968,620,161.83 |
